Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
clinical trials
life sciences
national blog main
national top stories
roche
2
×
san francisco blog main
san francisco top stories
amgen
biotech
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer drugs
cobimetinib
companion diagnostic
deals
detroit blog main
detroit top stories
dna sequencing
drugs
entrectinib
express scripts
fda
foundation medicine
indiana blog main
indiana top stories
investing
ipo
josh bilenker
keytruda
larotrectinib
loxo oncology
melanie nallicheri
merck
national
new england journal of medicine
new york blog main
What
cancer
drug
targets
2
×
approved
deeper
despite
dna
family
fda
fingerprint
genetic
going
hardest
hit
hottest
hunters
ipo
matter
medicine
medicines
nd
new
oks
proteins
ras
reels
research
revolution
second
time
tissues
tumor's
world
Language
unset
Current search:
targets
×
roche
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues